AbbVie and Anima Biotech pair up on discovery and development of mRNA Biology Modulators
AbbVie and Anima Biotech will develop mRNA biology modulators across three targets in oncology and immunology in a collaboration worth up to $580m.
Archives for January 12, 2023
Sanofi announces boost to strategic venture fund
Sanofi Ventures has announced an additional multi-year commitment from Sanofi, with an increase in capital to more than $750m to the evergreen venture fund.
EY: Signs biopharma industry ready to return to the big dealmaking table
Last year was a slow one in terms of dealmaking in the life sciences sector but the final quarter saw a major uptick, finds the EY annual M&A Firepower report.